We are at the forefront of innovative drug discovery, specializing in the development of targeted covalent inhibitors. Harnessing our extensive Research Chemistry Platform and deep expertise in Specialty Chemistry, we offer comprehensive solutions that accelerate the journey from concept to therapeutic reality.
Overview of Targeted Covalent Inhibitors
Targeted covalent inhibitors are a transformative class of therapeutics that form irreversible bonds with target proteins. By covalently attaching to specific amino acid residues, targeted covalent inhibitors achieve heightened potency and prolonged duration of action compared to reversible inhibitors. This approach allows for the selective modulation of challenging targets, including those previously deemed "undruggable".
Our Services
Custom Synthesis of Covalent Warheads
Backed by extensive small-molecule chemistry capabilities, our team specializes in the design and synthesis of covalent warheads. With experience in synthesizing over thousands of compounds, we have successfully prepared over several dozen different types of covalent warhead designs, of which 12 are readily available for immediate project use. This enables rapid exploration of electrophilic functionalities and provides our clients with a diverse, well-characterized collection of warhead options suitable for modern covalent drug discovery.
Design and Synthesis of Targeted Covalent Inhibitors
We also specialize in the design and synthesis of targeted covalent inhibitors, combining medicinal chemistry insight with structure-guided design principles. Our team supports clients in selecting appropriate warheads, optimizing molecular architecture, and generating high-quality targeted covalent inhibitors candidates tailored to specific protein targets. Through efficient synthetic execution and robust compound quality control, we help accelerate discovery programs and provide reliable molecules that enable deeper investigation into covalent mechanisms of action.
Assay Development and High-Throughput Screening
We develop bespoke biochemical and cellular assays to evaluate the activity of targeted covalent inhibitors. Our high-throughput screening capabilities enable rapid assessment of large compound libraries, expediting the identification of candidates with desired covalent binding profiles.
Our Synthesis Capacities
- Our chemistry platform integrates over a decade of expertise in conventional synthetic methods with the continuous adoption of innovative technologies. This enables us to access complex molecular architectures efficiently while maintaining strong intellectual property awareness. Our experienced chemists apply flexible and reliable synthetic strategies to meet the diverse needs of small-molecule research programs.
- To enhance throughput and reproducibility, we employ advanced robotic synthesizers capable of performing up to many reactions per day. Automated dispensing minimizes variability, improves overall reaction success rates, and significantly shortens development cycles.
- With a specialized purification team and fast-turnaround purification services, we ensure that all compounds undergo rigorous quality control and meet standardized delivery specifications. This integrated workflow guarantees dependable purity, consistency, and reliability across all project stages.
Frequently Asked Questions
Q1: How can you assist in improving the selectivity of targeted covalent inhibitors?
We enhance selectivity by integrating structural analysis with medicinal chemistry. By identifying unique reactive sites on the target protein and optimizing the electrophilic warheads, we design inhibitors that preferentially bind to the intended target, minimizing off-target effects.
Q2: Do you offer support for early-stage discovery or only for compounds already in development?
We support all stages of drug discovery, from concept initiation to lead optimization. Our services are customizable, allowing us to assist with initial hit identification, scaffold hopping, and the refinement of existing compounds.